• What best describes your title?*
  • 1. Which of the following tests provides the highest sensitivity and specificity for the diagnosis of bronchiectasis?*
  • 2. Which of the following airway clearance treatments is recommended against in patients with bronchiectasis?*
  • 3. Which cell-type has been implicated in the inflammatory portion of the vicious vortex that has been used to describe the pathophysiology of bronchiectasis, and is targeted by dipeptidyl peptidase 1 (DPP1)?*
  • 4. Brensocatib was shown in a Phase 2 clinical trial to significantly improve all of the following outcomes, except:*
  • How many patients do you currently see each month regarding non-cystic fibrosis bronchiectasis?
  • Learning Objectives
    Rows
  • Please provide us with feedback regarding your experience at the activity:
    Rows
  • Do you feel this activity was fair, balanced, and free of commercial bias?
  • This educational activity will result in a change in my role as a healthcare team member.
  • Based on your participation in this activity, choose the statement(s) that applies to how your role as a healthcare team member will change:

  • Attestation:

    AcademicCME designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditTM.

  • Date
     - -
    2 digit month, 2 digit day, 4 digit year
  • Should be Empty: